Literature DB >> 10772225

Ability of Lactobacillus and Propionibacterium strains to remove aflatoxin B, from the chicken duodenum.

H El-Nezami1, H Mykkänen, P Kankaanpää, S Salminen, J Ahokas.   

Abstract

The ability of Lactobacillus rhamnosus strains GG and LC-705 to remove AFB1 from the intestinal luminal liquid medium has been tested in vivo using a chicken intestinal loop technique. In this study, the GG strain of L. rhamnosus decreased AFB1 concentration by 54% in the soluble fraction of the luminal fluid within 1 min. This strain was more efficient in binding AFB1 compared with L. rhamnosus strain LC-705 (P < 0.05) that removed 44% of AFBl under similar conditions. Accumulation of AFB1 into the intestinal tissue was also determined. There was a 74% reduction in the uptake of AFB1 by the intestinal tissue, in the presence of L. rhamnosus strain GG compared with 63% and 37% in the case of Propionibacterium freudenreichii ssp. shermanii JS and L. rhamnosus strain LC-705, respectively. The complexes formed in vitro between either L. rhamnosus strain GG or L. rhamnosus strain LC-705 and AFB1 were stable under the luminal conditions for a period of 1 h.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10772225     DOI: 10.4315/0362-028x-63.4.549

Source DB:  PubMed          Journal:  J Food Prot        ISSN: 0362-028X            Impact factor:   2.077


  28 in total

1.  Key role of peptidoglycan on acrylamide binding by lactic acid bacteria.

Authors:  Dan Zhang; Wei Liu; Liang Li; Hong-Yu Zhao; Hong-Yang Sun; Ming-Han Meng; Sheng Zhang; Mei-Li Shao
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

2.  Retrospective and Prospective Look at Aflatoxin Research and Development from a Practical Standpoint.

Authors:  Noreddine Benkerroum
Journal:  Int J Environ Res Public Health       Date:  2019-09-27       Impact factor: 3.390

3.  Potential use of lactic acid bacteria Leuconostoc mesenteroides as a probiotic for the removal of Pb(II) toxicity.

Authors:  Young-Joo Yi; Jeong-Muk Lim; Suna Gu; Wan-Kyu Lee; Eunyoung Oh; Sang-Myeong Lee; Byung-Taek Oh
Journal:  J Microbiol       Date:  2017-03-31       Impact factor: 3.422

Review 4.  Targeting gut microbiota in hepatocellular carcinoma: probiotics as a novel therapy.

Authors:  Murphy L Y Wan; Hani El-Nezami
Journal:  Hepatobiliary Surg Nutr       Date:  2018-02       Impact factor: 7.293

5.  Lactobacillus rhamnosus strain GG modulates intestinal absorption, fecal excretion, and toxicity of aflatoxin B(1) in rats.

Authors:  S Gratz; M Täubel; R O Juvonen; M Viluksela; P C Turner; H Mykkänen; H El-Nezami
Journal:  Appl Environ Microbiol       Date:  2006-09-15       Impact factor: 4.792

6.  Surface binding of aflatoxin B(1) by lactic acid bacteria.

Authors:  C A Haskard; H S El-Nezami; P E Kankaanpää; S Salminen; J T Ahokas
Journal:  Appl Environ Microbiol       Date:  2001-07       Impact factor: 4.792

Review 7.  Potential uses of probiotics in clinical practice.

Authors:  Gregor Reid; Jana Jass; M Tom Sebulsky; John K McCormick
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

8.  In vitro efficacy of Myxococcus fulvus ANSM068 to biotransform aflatoxin B₁.

Authors:  Shu Guan; Lihong Zhao; Qiugang Ma; Ting Zhou; Ning Wang; Xinxu Hu; Cheng Ji
Journal:  Int J Mol Sci       Date:  2010-10-20       Impact factor: 5.923

9.  Intestinal mucus alters the ability of probiotic bacteria to bind aflatoxin B1 in vitro.

Authors:  S Gratz; H Mykkänen; A C Ouwehand; R Juvonen; S Salminen; H El-Nezami
Journal:  Appl Environ Microbiol       Date:  2004-10       Impact factor: 4.792

10.  Aflatoxin B(1) degradation by Stenotrophomonas maltophilia and other microbes selected using coumarin medium.

Authors:  Shu Guan; Cheng Ji; Ting Zhou; Junxia Li; Qiugang Ma; Tiangui Niu
Journal:  Int J Mol Sci       Date:  2008-08-22       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.